Product Information
LISDEXAMFETAMINE 30 MG CAPSULE is a generic product labeled by Sandoz Inc., priced at $3.0366 per EA under NDC 00781247701. Its NADAC has been published 30 times since Dec 3, 2025.
Strength
30 mg/1
Manufacturer
Sandoz Inc.NDC
00781247701
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LISDEXAMFETAMINE DIMESYLATEApproval Type
Generic (ANDA)
FDA Application
ANDA202836On Market Since
9/16/2025
Pharmacological Classes
Price Statistics
The NADAC for LISDEXAMFETAMINE 30 MG CAPSULE has been published 30 times since Dec 3, 2025, and over the history we have for it it has declined 11.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.0366 per EA |
|---|---|
| All-time high | $3.4369 (Dec 10, 2025) |
| All-time low | $2.9584 (Mar 18, 2026) |
| 52-week high | $3.4369 |
| 52-week low | $2.9584 |
| Median price | $3.0867 |
| Average price | $3.1313 |
| Largest weekly change | -6.4% (Feb 18, 2026) |
| Weeks tracked | 30 |
| Tracking since | Dec 3, 2025 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LISDEXAMFETAMINE 30 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for LISDEXAMFETAMINE 30 MG CAPSULE, manufactured by Sandoz Inc., is $3.0366 per EA (NDC 00781247701), effective Jun 24, 2026.
How has the price of LISDEXAMFETAMINE 30 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for LISDEXAMFETAMINE 30 MG CAPSULE has declined 11.6%. It has been tracked across 30 weekly CMS publications since Dec 3, 2025.
What are the highest and lowest recorded NADAC prices for LISDEXAMFETAMINE 30 MG CAPSULE?
Since Dec 3, 2025, the NADAC for LISDEXAMFETAMINE 30 MG CAPSULE has ranged from a low of $2.9584 (Mar 18, 2026) to a high of $3.4369 (Dec 10, 2025), with a median of $3.0867 per EA.
Are there cheaper alternatives to LISDEXAMFETAMINE 30 MG CAPSULE?
5 NADAC-published products share the same active ingredient, strength, and dosage form as LISDEXAMFETAMINE 30 MG CAPSULE, but none are currently priced below it.
Who manufactures LISDEXAMFETAMINE 30 MG CAPSULE?
LISDEXAMFETAMINE 30 MG CAPSULE (NDC 00781247701) is labeled by Sandoz Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification